Heart Disease Clinical Trials in Maryland

Showing 181-200 of 574 trials

Breethe Abiomed Recovery RegisTry (BART)

NCT05473130

The BART Registry intended to utilize observational data of the Abiomed Breethe OXY-1 System™ in real-world settings to drive best practice usage patterns, serve as a tool to measure and improve the quality of patient care and as a resource to inform us on the design of future studies.

Cardiopulmonary BypassARDSHeart Failure

Abiomed Inc.48 participantsStarted Mar 2021

Orlando, Florida, United States • Atlanta, Georgia, United States • College Park, Maryland, United States +3 more locations

Active Not RecruitingPhase 311 miles

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

NCT05202509

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD) who are not adequately controlled despite maximally tolerated lipid-lowering therapy.

Atherosclerotic Cardiovascular Disease

NewAmsterdam Pharma9,541 participantsStarted Feb 2022

Alexander City, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +588 more locations

Breethe Abiomed Recovery RegisTry (BART)

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Heart Disease Trials in Other Cities

Creating A Cardiorenal Multidisciplinary Team for Management HF and CKD Patients

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates

Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF

Individualized Nutrition Therapy for Preventing or Delaying Onset of Type-2 Diabetes

REmodeling the Left Ventricle With Atrial Modulated Pacing

Physiologic Pacing Registry

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

Dapagliflozin at Discharge on Hospital Heart Failure Readmission

Use of Oxandrolone to Promote Growth in Infants With HLHS

Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)

Rivet PVS Therapy in Group 2 PH-HFpEF

Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease

Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

Other Conditions in Maryland